efficacy of sublingual semaglutide Frontiers Efficacy of Semaglutide in a

M., Buse, J

Patients may experience anxiety, agitation, depression, or mood changes, particularly during the first few months of treatment

The MHRA encourages reporting of suspected adverse drug reactions through the Yellow Card scheme (yellowcard.mhra.gov.uk), which helps monitor medication safety across the UK population

But its also important to note that the study only consisted of 168 pregnant women who took the medications

Secondary prevention of CVD (adults) To reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight WEIGHT LOSS IN ADULTS RCT STEP 1 Study - Wegovy vs Placebo for Weight Loss in Adults Without Diabetes, NEJM (2021) [PubMed abstract] The STEP 1 study enrolled 1961 overweight or obese adults without diabetes Main inclusion criteria Age 18 years 1 failed attempt at dieting BMI 30 or 27 with one weight-related condition (e.g